Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Castrate Resistant Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)

Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Castrate Resistant Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)

Program Director:Eric Jonasch, MD, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

September 22, 2018 Houston Marriott West LoopBy the Galleria, 1750 West Loop South, Houston, TX 77027
Phone: 713-960-0111

Jointly Provided by
AmedcoandCancerNet, LLC

Educational Grants

Ferring Pharmaceuticals Inc
Eisai, Inc

For online registration and more information visit: www.cancernetus.com

Target Audience

This symposium is directed primarily to hematologists/oncologists, urologists, radiation oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in genitourinary cancers such as prostate cancer, renal cell carcinoma and urothelial bladder carcinoma. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Statement of Need/Program Overview

This symposiumis intended to improve care ofpatients with prostate cancer, renal cell carcinoma and urothelial bladder carcinomaby accelerating adoption of new guidelines and evidence-based practice change. The format will include didactic lectures from knownopinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. ;

Registration Fee
Registration fee includes buffet breakfast, lunch and syllabus book.

Early Registration Fee
(Up to 09/12/18)
Discounted Registration Fee
(09/13/18 to 09/22/18)
Physicians
$100.00
$130.00
Registered Nurses
$75.00
$95.00
Nurse Practitioners
$75.00
$95.00
Physician Assistants
$75.00
$95.00
Pharmacists
$75.00
$95.00
Fellows
$75.00
$95.00
*Industry
$350.00
$400.00

*Person(s) employed by for-profit organizations such as pharmaceutical and biotech companies, and financial institutions

Payment may be made: MC Visa Discover Check
Credit Card Number___________________________ Expiration Date_______________
Name and address________________________________________________________
________________________________________________________________________
________________________________________________________________________
Signature________________________________________________________________
as given on the monthly credit card statement
No refund. Substitution is allowed.

Please make checks payable to CancerNet. Mail checks to CancerNet, 860 Hebron Pkwy, Suite 1104, Lewisville, TX 75057

To reserve your place for the meeting, please complete the registration form and fax it 443-267-0016. For questions if any please call Brian Waggoner at 972-459-5222 or E-mail: [email protected]

Physicians/Nurses/Pharmacists

aaIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and CancerNet.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CCredit Designation

Amedco LLC designates this live activity for a maximum of 6 AMA PRA Category 1 CreditsTM for physicians, 6 contact hours for nurses and 6 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.